Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,003 total articles
Collegium Pharmaceutical Executive Vice President and General Counsel Dieter David sold 13,976 shares on March 18, 2026, receiving about $488,099. The transaction, executed under a Rule 10b5-1 plan adopted December 5, 2025, leaves David with 77,071 shares. The company is trading around $35.50, down roughly 22% year-to-date, even as InvestingPro Fai…
Bicara Therapeutics CEO Claire Mazumdar exercised options to acquire 14,900 shares at $3.7898 and sold those 14,900 shares between March 18 and March 20, 2026 for about $282,365. The sales came after an 80% six-month rally and amid a recent $172.5 million underwritten public offering. InvestingPro flags the stock as slightly overvalued at the curre…
Mari Steinmetz, Kohl’s senior executive in charge of human resources, disclosed a March 20 sale of 1,583 shares at $12.81 worth $20,278. Filings show additional activity earlier in March including sizeable purchases and a separate disposal. The company recently reported fourth-quarter 2025 results that beat on EPS but slightly missed revenue foreca…
Equity LifeStyle Properties director David J Contis sold 3,000 shares of the company's common stock on March 18, 2026, realizing $201,659 at a weighted average price of $67.2199. On the same day, 8,000 shares held by the Contis Family Trust were disposed of as a gift. The company recently reported Q4 2025 results that beat EPS expectations but miss…
Jeffrey Housman, Chief People & Services Officer at Restaurant Brands International Inc (QSR), sold 20,000 common shares on March 20, 2026 for roughly $1.46 million and exercised options on 20,000 shares for about $1.11 million the same day. The transactions leave Housman with just over 162,076 common shares. The moves come as QSR trades near its 5…
Marketwise, Inc. (NASDAQ: MKTW) reported insider sales by Chief Financial Officer Erik Mickels totaling approximately $140,099 across two transactions on March 18 and 19, 2026. The disposals reduced Mickels' direct holdings to 85,064 shares. The sales occurred against a backdrop of solid short-term share price gains, an InvestingPro valuation asses…
Michael Moore, president of Viemed Healthcare, INC. (NASDAQ: VMD), disposed of 136,802 common shares in several transactions between March 18 and March 20, 2026, generating about $1.23 million. The sales were made indirectly through Moore Faster LLC. Viemed recently reported fourth-quarter 2025 results that beat on EPS but missed on revenue, while …
Pangaea Logistics Solutions CFO Gianni DelSignore sold 23,779 shares on March 18-19, 2026 to satisfy tax withholding from restricted stock unit vesting, generating roughly $166,215. The company recently reported fourth-quarter 2025 results that topped revenue estimates but missed on earnings per share, leaving investor reaction mixed.
David T. Bottoms, General Manager of Marketplace at Upwork Inc. (NASDAQ: UPWK), sold 18,575 shares of Upwork common stock across March 18-19, 2026, for roughly $222,957 and separately received 20,908 shares through the exercise of restricted stock units on March 18. The sales included mandated sell-to-cover transactions tied to RSU vesting and were…
Kurt M. Eckert, a director at Miami International Holdings, Inc. (MIAX), sold 37,917 shares on March 19, 2026, for $1,478,763 and exercised options to buy 12,917 shares at $12 apiece. The sale was executed under a Rule 10b5-1 trading plan adopted December 18, 2025. MIAX recently reported robust fourth-quarter 2025 financials and rising market share…
Upwork President and CEO Hayden Brown sold 23,745 shares of the company's common stock on March 18, 2026, receiving about $292,343 from those transactions, while also exercising restricted stock units that converted into 46,410 shares the same day. The stock is trading near its 52-week low, and recent corporate moves include matched-or-better-than-…
A reported insider sale at Mohawk Industries saw 6,000 shares change hands on March 19-20, 2026, totaling $581,950. The transactions occurred as the flooring manufacturer's stock hovered near its 52-week low. Mohawk recently reported Q4 2025 results that beat analyst expectations for both adjusted EPS and revenue. InvestingPro analysis cited in rep…
Lizette Benedi Herraiz, General Counsel of Strategic Education, Inc. (NASDAQ: STRA), disposed of 2,982 shares on March 18, 2026 under a Rule 10b5-1 plan, generating proceeds of $238,202. The sale, executed at a weighted average price of $79.88 and occurring within a $79.36 to $80.30 range, follows a quarter in which the company topped EPS and reven…
Ajay Madan Gopal, chief financial officer of TheRealReal, Inc. (NASDAQ: REAL), sold 51,585 shares on March 19, 2026 at $9.29 per share to satisfy withholding taxes related to a performance award. The trade, disclosed on a Form 4 filing, generated $479,224 and left the CFO with 1,179,307 shares. The company recently reported stronger-than-expected f…
Jodi Devlin, TriSalus Life Sciences' Chief of Clinical Operations, sold 3,107 shares of the company's common stock across three transactions between March 11 and March 16, 2026, for a combined $13,171. The trades occurred at prices between $4.09 and $4.13 per share. TriSalus shares are trading below those levels at $3.92 and the company is due to r…
TriSalus Life Sciences Chief Commercial Officer Richard Marshak sold 3,457 shares of the company's common stock across three transactions between March 11 and March 16, 2026, raising $14,209. The disposals were made to satisfy tax withholding obligations tied to vesting restricted stock units and are not characterized as discretionary sales. The co…
Bryan F. Cox, Chief of Research at TriSalus Life Sciences, sold 3,184 shares of the company's common stock across three transactions between March 11 and March 16, 2026, generating about $13,085. The trades were made to satisfy tax obligations tied to vesting restricted stock units and were not discretionary. Cox retains direct ownership of 163,415…
TriSalus Life Sciences Chief Regulatory Officer Jennifer Stevens sold 3,530 shares of common stock across three transactions between March 11 and March 16, 2026, to satisfy tax obligations tied to vested restricted stock units. The sales, executed at prices between $4.09 and $4.13, generated roughly $14,509 in proceeds. The filings note the sales w…
TriSalus Life Sciences CEO Mary T. Szela disposed of 20,302 shares across two trades in March to satisfy tax obligations tied to vesting restricted stock units. The sales, executed on March 11 and March 17, raised $79,382 in aggregate. The moves coincide with mixed corporate results: meaningful revenue growth in Q4 2025 and fiscal 2025, an improved…
Opko Health director John A. Paganelli purchased 10,000 shares of the company's common stock on March 20, 2026, at $1.135 per share, totaling $11,350. The transaction occurs as OPKO shares trade near a 52-week low and follow fourth-quarter results that beat expectations. The company also announced a board appointment to fill a vacancy.
Townsquare Media Executive Vice President of Finance Operations and Technology Scott Schatz sold nearly 29,000 Class A shares on March 19, 2026, for about $147,218 while receiving a separate, immediately vested stock award the day prior. The company recently reported a fourth-quarter 2025 earnings miss and revenue shortfall, and the stock has trade…
Aldeyra Therapeutics director Richard Douglas purchased 70,000 shares on March 19, 2026, investing $98,000 as the stock traded near a 52-week low. The move comes amid regulatory pushback from the FDA over reproxalap and the announced departure of the company's chief development officer. Analysts remain divided on the stock's outlook.
Immunovant Chief Legal Officer Christopher Van Tuyl sold 2,877 shares on March 18, 2026, for $24.97 each, a transaction totaling $71,838 executed to satisfy tax withholding on vested restricted stock units. The shares trade below the sale price at $22.99 but remain about 60% higher than six months ago. The company also reported a third-quarter 2026…
Jane Tunnell, chief marketing officer at Dell Technologies Inc. (NASDAQ:DELL), sold 28,529 shares of Class C common stock on March 18, 2026, in a transaction valued at $4,350,957. The sale comes amid a year of strong equity performance for Dell and concurrent product announcements aimed at expanding the company's AI offerings.
Insmed Chair and CEO William Lewis sold 10,700 shares of company stock on March 19, 2026, generating about $1.5 million, and exercised options to acquire an additional 10,699 shares. The moves leave Lewis with substantive direct and indirect holdings while the company posts robust revenue gains alongside an EPS shortfall and sets aggressive 2026 gu…
